| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2530 | 2014 |
| A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer FR Khuri, J Nemunaitis, I Ganly, J Arseneau, IF Tannock, L Romel, ... Nature medicine 6 (8), 879-885, 2000 | 1434 | 2000 |
| Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1075 | 2016 |
| The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Şenbabaoğlu, A Desrichard, JJ Havel, MG Dalin, N Riaz, ... JCI insight 1 (17), 2016 | 691 | 2016 |
| Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer J Nemunaitis, F Khuri, I Ganly, J Arseneau, M Posner, E Vokes, J Kuhn, ... Journal of Clinical Oncology 19 (2), 289-298, 2001 | 629 | 2001 |
| A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer I Ganly, D Kirn, SG Eckhardt, GI Rodriguez, DS Soutar, R Otto, ... Clinical Cancer Research 6 (3), 798-806, 2000 | 581 | 2000 |
| Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial J Nemunaitis, I Ganly, F Khuri, J Arseneau, J Kuhn, T McCarty, S Landers, ... Cancer research 60 (22), 6359-6366, 2000 | 562 | 2000 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 549* | 2021 |
| The mutational landscape of adenoid cystic carcinoma AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ... Nature genetics 45 (7), 791-798, 2013 | 472 | 2013 |
| Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease I Landa, I Ganly, TA Chan, N Mitsutake, M Matsuse, T Ibrahimpasic, ... The Journal of Clinical Endocrinology & Metabolism 98 (9), E1562-E1566, 2013 | 466 | 2013 |
| Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance RM Tuttle, JA Fagin, G Minkowitz, RJ Wong, B Roman, S Patel, B Untch, ... JAMA Otolaryngology–Head & Neck Surgery 143 (10), 1015-1020, 2017 | 455 | 2017 |
| Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation LGT Morris, AM Kaufman, Y Gong, D Ramaswami, LA Walsh, Ş Turcan, ... Nature genetics 45 (3), 253-261, 2013 | 437 | 2013 |
| Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus–associated oropharyngeal cancer LGT Morris, AG Sikora, SG Patel, RB Hayes, I Ganly Journal of clinical oncology 29 (6), 739, 2011 | 404 | 2011 |
| Postoperative complications of salvage total laryngectomy I Ganly, S Patel, J Matsuo, B Singh, D Kraus, J Boyle, R Wong, N Lee, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 381 | 2005 |
| Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy IJ Nixon, I Ganly, SG Patel, FL Palmer, MM Whitcher, RM Tuttle, A Shaha, ... Surgery 151 (4), 571-579, 2012 | 363 | 2012 |
| Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study I Ganly, SG Patel, B Singh, DH Kraus, PG Bridger, G Cantu, A Cheesman, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2005 | 361 | 2005 |
| Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy NG Iyer, LGT Morris, RM Tuttle, AR Shaha, I Ganly Cancer 117 (19), 4439-4446, 2011 | 351 | 2011 |
| Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcome I Ganly, S Patel, J Shah Cancer 118 (1), 101-111, 2012 | 347 | 2012 |
| Survival outcomes after treatment of cancer of the oral cavity (1985–2015) DK Zanoni, PH Montero, JC Migliacci, JP Shah, RJ Wong, I Ganly, ... Oral oncology 90, 115-121, 2019 | 331 | 2019 |
| Immunogenic neoantigens derived from gene fusions stimulate T cell responses W Yang, KW Lee, RM Srivastava, F Kuo, C Krishna, D Chowell, ... Nature medicine 25 (5), 767-775, 2019 | 316 | 2019 |
